ImmuneOncia Therapeutics이뮨온시아
424870 · KOSDAQ · ₩424870 · 이뮨온시아
₩2,830▼ ₩20 (0.70%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | |
|---|---|
| Revenue | ₩111M |
| Operating income | −₩28B |
| Net income | −₩27B |
| Net income to shareholders | −₩27B |
Balance sheet
| 2025 | |
|---|---|
| Total assets | ₩33B |
| Current assets | ₩27B |
| Cash and equivalents | ₩8.2B |
| Total liabilities | ₩4.7B |
| Current liabilities | ₩4.3B |
| Total equity | ₩28B |
| Shareholders' equity | ₩28B |
Cash flow
| 2025 | |
|---|---|
| Cash from operations | −₩23B |
| Capital spending | ₩323M |
| Free cash flow | −₩23B |
Consolidated where available. Amounts in won.
Also known as: ImmuneOncia Therapeutics / 이뮨온시아 / 424870 / KRX:424870
Source: KRX statistical information